Evidence map›Paper›PMID 34066602›Full record

ArticleTropical medicine and infectious disease2021

Blood Culture Testing Outcomes among Non-Malarial Febrile Children at Antimicrobial Resistance Surveillance Sites in Uganda, 2017-2018.

Rogers Kisame, Robinah Najjemba, Johan van Griensven, Freddy Eric Kitutu, Kudakwashe Takarinda, Pruthu Thekkur, Alexandre Delamou, Richard Walwema, Francis Kakooza, Ibrahim Mugerwa and 6 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rogers KisameInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.ORCID 0000-0002-6492-2341
Robinah NajjembaPublic Health Consultant, 1211 Geneva, Switzerland.ORCID 0000-0003-4691-6906
Johan van GriensvenDepartment of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Freddy Eric KitutuSustainable Pharmaceutical Systems (SPS) Unit, Department of Pharmacy, Makerere University School of Health Sciences, Kampala 920102, Uganda.ORCID 0000-0003-2277-9572
Kudakwashe TakarindaInternational Union against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.
Pruthu ThekkurInternational Union against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.
Alexandre DelamouMaferinyah Training and Research Centre, Conakry 331027, Guinea.ORCID 0000-0002-9397-7106
Richard WalwemaInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.
Francis KakoozaInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.ORCID 0000-0003-4047-6620
Ibrahim MugerwaUganda National Health Laboratory Services, Kampala 920102, Uganda.ORCID 0000-0003-4462-2867
Musa SekamatteNational One Health Platform, Ministry of Health, Kampala 920102, Uganda.
Kimera RobertInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.
Thomas KatairoInfectious Diseases Research Collaboration, Kampala 920102, Uganda.ORCID 0000-0002-2002-8911
Marc Sam OpolloFaculty of Health Sciences, Lira University, Lira P.O. Box 1035, Uganda.ORCID 0000-0003-1456-1696
Morgan OtitaInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.
Mohammed LamordeInfectious Disease Institute, College of Health Sciences, Makerere University, Kampala 920102, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood culture (BC) processes are critical to the utility of diagnostic testing, bloodstream infection (BSI) management, and antimicrobial resistance (AMR) surveillance. While Uganda has established BC guidelines, often laboratory practice does not meet the desired standards. This compromises pathogen recovery, reliability of antimicrobial susceptibility testing, and diagnostic test utility. This study assessed laboratory BC process outcomes among non-malarial febrile children below five years of age at five AMR surveillance sites in Uganda between 2017 and 2018. Secondary BC testing data was reviewed against established standards. Overall, 959 BC specimens were processed. Of these, 91% were from female patients, neonates, infants, and young children (1-48 months). A total of 37 AMR priority pathogens were identified;

Indexed as

antimicrobial resistanceantimicrobial susceptibility testingblood culturebloodstream infectionsfebrile illnessoperational researchSORT IT

Identifiers

PMID34066602
PMCPMC8167719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.